能量平衡的损失有助于在状细胞疾病中肝损伤的发展
Lucía Beltrán-Camacho1, Mercedes Vallejo-Mudarra2, Isabel Pozuelo-Sánchez2
1Department of Cell Biology, Physiology and Immunology, University of Cordoba, ceiA3 Campus of International Excellence in Agri-Food, Cordoba, Spain; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain.
Molecular metabolism
|March 7, 2026
概括
状细胞疾病 (SCD) 通过未知的机制导致肝损伤. 这项研究使用蛋白质组学揭示了与肝功能受损,能量失衡和SCD小鼠泡细胞积累相关的蛋白质变化.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 状细胞疾病 (SCD) 涉及异常的血红蛋白 (HbS),导致红细胞损伤,血液溶解性贫血和组织损伤.
- 肝功能在SCD中经常受到损害,但潜在的病理机制尚不清楚.
研究的目的:
- 在状细胞疾病 (SCD) 的小鼠模型中研究肝损伤的分子机制.
- 在SCD中识别与肝功能受损相关的蛋白质基因变化.
主要方法:
- 使用一种无标签的定量蛋白质学方法来比较SCD小鼠和健康对照中的蛋白质表达.
- 进行分子和功能分析以验证蛋白质组发现.
主要成果:
- 在SCD小鼠和对照小鼠之间发现了蛋白质表达特征的显著差异.
- 观察到与肝功能受损,贫血,线粒体功能障碍和脂质代谢变化相关的分子变化.
- 在SCD小鼠中证实了一种新的肝脏能量平衡失衡和泡细胞积累.
结论:
- 这项研究为SCD肝病的复杂机制提供了新的见解.
- 确定了在状细胞病患者中管理肝脏并发症的潜在治疗点.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
305
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
305
Homeostatic Imbalance
41.3K
Homeostasis is the maintenance of a stable internal environment within the body, which is crucial for the proper functioning of cells, tissues, organs, and organ systems. The body has various control mechanisms that work together to regulate various physiological parameters such as temperature, blood pressure, pH balance, and fluid balance, to name a few. These control mechanisms are based on feedback loops that can be either positive or negative.
However, sometimes these feedback loops fail,...
However, sometimes these feedback loops fail,...
41.3K
Overview of Lipid Metabolism
6.3K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
245
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
245
Liver Physiology
4.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.1K
Inborn Errors of Metabolism
967
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
967


